Jubilant HollisterStier nets US government contract to increase activity at its growing facility

A pharmaceutical contract manufacturer that has been growing its presence in the US has secured itself a sizable contract from the US government.

Jubilant HollisterStier, a subsidiary of Singapore-based Jubilant Pharma Limited, has entered into a cooperative agreement for $149.6 million with the Army Contracting Command. The deal is also in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) on behalf of BARDA.

The effort, which was funded under the American Rescue Plan, will enable Jubilant HollisterStier to double its injectable filling production capacity at its Spokane, WA manufacturing facility for a total cost $193 million. The project is slated completion in 2025, according to the company.

The company has a history of supporting both HHS and the DOD with biodefense and medical countermeasure programs, including production for national preparedness efforts.

“Jubilant HollisterStier LLC is committed to making the US pharmaceutical supply chain more resilient…
Click here to view original post